awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33680292-82870C68-17B2-40A1-AD19-700C3850AB84
Q33680292-82870C68-17B2-40A1-AD19-700C3850AB84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33680292-82870C68-17B2-40A1-AD19-700C3850AB84
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.
P2860
Q33680292-82870C68-17B2-40A1-AD19-700C3850AB84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33680292-82870C68-17B2-40A1-AD19-700C3850AB84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7380e5ff49833a32b6695eef4e546456da54cfbe
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.